A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a California resident who died of a rare form of cancer. The family filed a suit against the company claiming that its baby powder contains a carcinogen. Mae Moore died in 2021 from mesothelioma, cancer of the mesothelium –… The post Johnson & Johnson to pay $966 million to cancer victim’s family appeared first on Drug Discovery and Development.| Drug Discovery and Development
New Jersey’s Department of Environmental Protection (DEP) has filed a lawsuit against Pfizer, Johnson & Johnson, Honeywell and several real estate companies, claiming there is toxic waste on an old pharmaceutical plant site, contaminating the groundwater. The plant, located in Morris Plains, was operational from the 1950s to the 1980s under Warner-Lambert, which Pfizer acquired… The post NJ sues Pfizer and others for water contamination appeared first on Drug Discovery and Development.| Drug Discovery and Development
BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.” The post Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus appeared first on The Daily Upside.| The Daily Upside
The stocks are included in the investment bank's "Conviction List - Directors' Cut" group of buy-rated companies.| CNBC
UTA’s Junzhou Huang secures $3.1M NIH grant to advance AI-driven antibody drug discovery, aiming to speed pandemic response and lower development costs.| Dallas Innovates
A fully independent clinical trial researchers thought might disprove a cardiac device made by Shockwave Medical, the company that Johnson & Johnson is buying for $13 billion, ended up providing some support for the device’s utility.| Healthcare Weekly
By embracing diverse perspectives, actively countering biases, and holding leaders accountable, organizations can create environments where every employee has the opportunity to succeed.| Bluesky Thinking
David Levine and Bruce Wydick Americans—and the world—should cheer the government’s news Friday to lift the pause on the distribution of the Johnson & Johnson COVID-19 vaccine. The decision wi…| Across Two Worlds